Copeptin and its clinical implications in the setting of vasovagal syncope

dc.contributor.authorYalta, Kenan
dc.date.accessioned2024-06-12T11:17:37Z
dc.date.available2024-06-12T11:17:37Z
dc.date.issued2017
dc.departmentTrakya Üniversitesien_US
dc.description.abstract[Abstract Not Available]en_US
dc.identifier.doi10.1016/j.ijcard.2017.03.008
dc.identifier.endpage28en_US
dc.identifier.issn0167-5273
dc.identifier.issn1874-1754
dc.identifier.pmid28619331en_US
dc.identifier.scopus2-s2.0-85020399280en_US
dc.identifier.scopusqualityQ1en_US
dc.identifier.startpage28en_US
dc.identifier.urihttps://doi.org/10.1016/j.ijcard.2017.03.008
dc.identifier.urihttps://hdl.handle.net/20.500.14551/24778
dc.identifier.volume242en_US
dc.identifier.wosWOS:000405455500026en_US
dc.identifier.wosqualityQ2en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherElsevier Ireland Ltden_US
dc.relation.ispartofInternational Journal Of Cardiologyen_US
dc.relation.publicationcategoryDiğeren_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectArginine-Vasopressin Increasesen_US
dc.titleCopeptin and its clinical implications in the setting of vasovagal syncopeen_US
dc.typeLetteren_US

Dosyalar